These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7007505)

  • 1. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.
    Adams DO; Marino PA
    J Immunol; 1981 Mar; 126(3):981-7. PubMed ID: 7007505
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.
    Adams DO
    J Immunol; 1980 Jan; 124(1):286-92. PubMed ID: 6985641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
    Adams DO; Marino PA; Meltzer MS
    J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
    Koren HS; Meltzer MS; Adams DO
    J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases.
    Adams DO; Kao KJ; Farb R; Pizzo SV
    J Immunol; 1980 Jan; 124(1):293-300. PubMed ID: 6985642
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of tumor cytolytic/cytostatic factor(s) by in vitro cisplatin treated macrophages: enhanced tumoricidal activity by increase in osmotic fragility of target cells.
    Singh SM; Sodhi A; Pai K; Geetha B
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):67-73. PubMed ID: 1804054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
    Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
    J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
    [No Abstract]   [Full Text] [Related]  

  • 10. The requirement for macrophages in the augmentation of natural killer cell activity by BCG.
    Tracey DE
    J Immunol; 1979 Aug; 123(2):840-5. PubMed ID: 222845
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.
    Adams DO; Pike MC; Snyderman R
    J Immunol; 1981 Jul; 127(1):225-30. PubMed ID: 7240742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
    Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
    J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets.
    Adams DO; Johnson WJ; Fiorito E; Nathan CF
    J Immunol; 1981 Nov; 127(5):1973-7. PubMed ID: 7299120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
    Meltzer MS; Ruco LP; Boraschi D; Nacy CA
    J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity.
    Tracey DE; Adkinson NF
    J Immunol; 1980 Jul; 125(1):136-41. PubMed ID: 6991599
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.
    Day DB; Zachariades NA; Gooding LR
    Cell Immunol; 1994 Aug; 157(1):223-38. PubMed ID: 8039246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG-activated macrophages: comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Adams DO; Koren HS
    Adv Exp Med Biol; 1979; 121B():195-201. PubMed ID: 397747
    [No Abstract]   [Full Text] [Related]  

  • 18. M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways.
    Bansal K; Narayana Y; Patil SA; Balaji KN
    J Leukoc Biol; 2009 May; 85(5):804-16. PubMed ID: 19228814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.